{'fraction_non_alphanumeric': 0.020754716981132074, 'fraction_numerical': 0.0, 'mean_word_length': 5.6375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man.

Although beta-adrenoceptor antagonists were first developed for their potential therapeutic uses in cardiac disease, it was soon recognized during clinical trials that they had effects on the central nervous system, some ofthem unwanted, but others ofpossible therapeutic value. This paper reviews some recent developments in this area of beta-adrenoceptor clinical pharmacology, earlier studies having been the subject of other reviews.'